TP53 and neoplasm: We aimed to investigatethe synergistic anti-tumor efficacy of BMP4 and LTL in two human glioblastoma cell lines(U87MG with p53 wild-type and U251 with p53 mutant-type), targeting autophagy flux innutrient-deficient growth medium.